CHARLES SCHWAB INVESTMENT MANAGEMENT INC - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 185 filers reported holding CYTOKINETICS INC in Q4 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2023$22,292,735
-11.4%
756,712
-1.9%
0.01%
-14.3%
Q2 2023$25,152,564
-1.1%
771,078
+6.7%
0.01%
-12.5%
Q1 2023$25,431,144
-23.6%
722,681
-0.5%
0.01%
-27.3%
Q4 2022$33,269,077
-2.6%
726,082
+3.0%
0.01%
-8.3%
Q3 2022$34,168,000
+43.3%
705,212
+16.2%
0.01%
+50.0%
Q2 2022$23,849,000
+7.9%
606,995
+1.1%
0.01%
+14.3%
Q1 2022$22,104,000
-17.1%
600,492
+2.7%
0.01%
-12.5%
Q4 2021$26,649,000
+21.9%
584,666
-4.4%
0.01%
+14.3%
Q3 2021$21,857,000
+116.0%
611,533
+19.6%
0.01%
+133.3%
Q2 2021$10,119,000
-8.1%
511,304
+8.0%
0.00%
-25.0%
Q1 2021$11,015,000
+15.7%
473,519
+3.3%
0.00%0.0%
Q4 2020$9,522,000
-2.0%
458,182
+2.1%
0.00%0.0%
Q3 2020$9,718,000
+6.0%
448,851
+15.4%
0.00%0.0%
Q2 2020$9,167,000
+111.5%
388,889
+5.8%
0.00%
+33.3%
Q1 2020$4,334,000
+13.9%
367,535
+2.5%
0.00%
+50.0%
Q4 2019$3,804,000
-5.0%
358,522
+1.8%
0.00%0.0%
Q3 2019$4,006,000
+7.9%
352,021
+6.7%
0.00%0.0%
Q2 2019$3,711,000
+57.5%
329,825
+13.3%
0.00%0.0%
Q1 2019$2,356,000
+30.9%
291,219
+2.3%
0.00%
+100.0%
Q4 2018$1,800,000
-37.1%
284,755
-2.0%
0.00%
-50.0%
Q3 2018$2,862,000
+36.9%
290,494
+15.4%
0.00%0.0%
Q2 2018$2,090,000
+28.4%
251,805
+11.4%
0.00%
+100.0%
Q1 2018$1,628,000
-18.8%
225,992
-8.1%
0.00%
-50.0%
Q4 2017$2,004,000
-54.4%
245,793
-19.0%
0.00%
-50.0%
Q3 2017$4,399,000
+29.7%
303,347
+8.3%
0.00%
+33.3%
Q2 2017$3,391,000
+65.8%
280,205
+76.1%
0.00%
+50.0%
Q1 2017$2,045,000
+32.0%
159,096
+24.8%
0.00%0.0%
Q4 2016$1,549,000
+40.3%
127,442
+6.0%
0.00%
+100.0%
Q3 2016$1,104,000
+103.7%
120,204
+110.5%
0.00%0.0%
Q2 2016$542,000
+34.5%
57,1000.0%0.00%0.0%
Q1 2016$403,000
-32.6%
57,1000.0%0.00%0.0%
Q4 2015$598,000
+94.2%
57,100
+24.4%
0.00%
Q3 2015$308,000
-0.3%
45,9000.0%0.00%
Q2 2015$309,000
-1.0%
45,9000.0%0.00%
Q1 2015$312,000
-15.2%
45,9000.0%0.00%
-100.0%
Q4 2014$368,000
+127.2%
45,9000.0%0.00%
Q3 2014$162,000
-26.4%
45,9000.0%0.00%
Q2 2014$220,000
-49.7%
45,9000.0%0.00%
-100.0%
Q1 2014$437,000
+90.0%
45,900
+30.0%
0.00%
Q4 2013$230,000
-13.2%
35,3000.0%0.00%
-100.0%
Q3 2013$265,00035,3000.00%
Other shareholders
CYTOKINETICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
BVF INC/IL 2,106,989$14,159,0002.50%
Healthcare Value Capital, LLC 100,000$672,0000.71%
First Light Asset Management, LLC 218,792$1,470,0000.69%
IRONWOOD INVESTMENT MANAGEMENT LLC 435,202$2,925,0000.67%
TFS CAPITAL LLC 899,951$6,048,0000.59%
SPHERA FUNDS MANAGEMENT LTD. 422,250$2,838,0000.28%
ALGERT GLOBAL LLC 73,181$492,0000.27%
LANSDOWNE PARTNERS (UK) LLP 2,321,865$15,603,0000.13%
Leisure Capital Management 17,567$118,0000.12%
Rotella Capital Management, Inc. 15,778$106,0000.09%
View complete list of CYTOKINETICS INC shareholders